Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more
MarketWatch
MarketWatch
MarketWatch
MarketWatch
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.